2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-(4-(trifluoromethoxy)benzyloxy)phenyl)ethynyl)pyridin-2-yl)propan-2-ol

ID: ALA4080531

PubChem CID: 89619265

Max Phase: Preclinical

Molecular Formula: C31H20F7N5O3

Molecular Weight: 643.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OC(Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(C#Cc2ccc(OCc3ccc(OC(F)(F)F)cc3)cc2)cn1

Standard InChI:  InChI=1S/C31H20F7N5O3/c32-23-8-13-26(27(33)15-23)29(44,18-43-19-40-41-42-43)30(34,35)28-14-7-21(16-39-28)2-1-20-3-9-24(10-4-20)45-17-22-5-11-25(12-6-22)46-31(36,37)38/h3-16,19,44H,17-18H2

Standard InChI Key:  GZZPVZNGVLQEPO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
   22.4521  -17.9947    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.4563  -18.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1619  -18.3997    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.7464  -19.2288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0345  -18.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7464  -20.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1700  -19.2288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0322  -20.4568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0319  -21.2774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7443  -21.6909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4584  -21.2738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4553  -20.4546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0345  -17.9947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.6978  -17.5117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4453  -16.7304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6239  -16.7304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3674  -17.5117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7422  -18.4074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.1675  -20.0511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8785  -20.4597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5872  -20.0510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5846  -19.2255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8771  -18.8165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2982  -20.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0106  -20.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7230  -21.2721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7221  -22.0941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4337  -22.5058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1460  -22.0921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1422  -21.2666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4301  -20.8627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3258  -20.0460    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.7453  -22.5081    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   28.8551  -22.4982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5614  -22.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2705  -22.4931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2692  -23.3075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9776  -23.7135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6848  -23.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6792  -22.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9704  -22.0787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3945  -23.7075    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.3985  -24.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1082  -24.9298    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.6928  -24.9367    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.3905  -25.3412    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  1  0
  4  5  1  0
  4  6  1  0
  2  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  6  1  0
  5 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
  4 18  1  0
  7 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  7  1  0
 24 25  3  0
 21 24  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
  8 32  1  0
 10 33  1  0
 29 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 36  1  0
 39 42  1  0
 42 43  1  0
 43 44  1  0
 43 45  1  0
 43 46  1  0
M  END

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ERG11 Cytochrome P450 51 (617 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lanosterol 14-alpha demethylase (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 643.52Molecular Weight (Monoisotopic): 643.1454AlogP: 5.90#Rotatable Bonds: 9
Polar Surface Area: 95.18Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.66CX Basic pKa: 0.32CX LogP: 7.37CX LogD: 7.37
Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.16Np Likeness Score: -1.33

References

1. Yates CM, Garvey EP, Shaver SR, Schotzinger RJ, Hoekstra WJ..  (2017)  Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.,  27  (15): [PMID:28651982] [10.1016/j.bmcl.2017.06.037]

Source